[248 Pages Report] Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds. With advent of tissue …
Continue reading “Tissue Engineered Skin Substitute Market is expected to reach US$ 4.13 Bn by 2029”